Journal of Invasive Cardiology

• 

  Publication Venue For

  • Different Spasmolytic Regimens (Nitroglycerin vs Verapamil) and the Incidence of Radial Artery Occlusion After Transradial Catheterization..  30:461-464. 2018
  • High-Sensitivity Troponin in Patients With Coronary Artery Endothelial Dysfunction..  30:406-410. 2018
  • Lower Repeat Revascularization Rates Among Patients With Prior Coronary Artery Bypass Graft Surgery are Due to Lack of Adequate Target Vessels..  30:51-55. 2018
  • Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention..  30:18-22. 2018
  • Migration of Intraaortic Balloon Pump Placed Via the Axillary Artery..  30:E11. 2018
  • Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Low-Intermediate Surgical Risk Patients: A Systematic Review and Meta-Analysis.  29:208-216. 2017
  • Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Low-Intermediate Surgical Risk Patients: A Systematic Review and Meta-Analysis..  29:209-216. 2017
  • Comparison Between Radial Approach and Femoral Approach With Vascular Closure Devices on the Occurrence of Access-Site Complications and Periprocedural Bleeding After Percutaneous Coronary Procedures: A Systematic Review and Meta-Analysis.  28:475-481. 2016
  • Comparison Between Radial Approach and Femoral Approach With Vascular Closure Devices on the Occurrence of Access-Site Complications and Periprocedural Bleeding After Percutaneous Coronary Procedures: A Systematic Review and Meta-Analysis..  28:473-479. 2016
  • Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation..  28:133-138. 2016
  • A Call for Comprehensive Forearm Access?.  28:8-9. 2016
  • Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial..  27:468-473. 2015
  • ECMO and the Intraaortic Balloon Pump: In Search of the Ideal Mechanical Circulatory Support Device..  27:459-460. 2015
  • De-implementing the Allen's Test..  27:E74. 2015
  • Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents..  26:420-426. 2014
  • Transcatheter aortic valve replacement for aortic bioprosthetic valve failure with cardiogenic shock..  25:625-626. 2013
  • Migraine headaches following mitral valvuloplasty: Koch's postulates finally satisfied?.  25:E120-E123. 2013
  • Off-label closure during CLOSURE study..  24:608-611. 2012
  • Percutaneous pulmonary valve implantation in left pulmonary artery branch in a patient with a functional single lung..  24:E202-E204. 2012
  • Faster, Safer, Better: The New Paradigm for Managing ST-Segment Elevation Myocardial Infarction.  23:1-2. 2011
  • Transradial PCI in women: problem solved or clinical equipoise?.  23:4 p preceding 101. 2011
  • A Case Report of Combining Procedural and Pharmacological Strategies to Reduce Bleeding Risk in a High Risk Patient Undergoing Percutaneous Coronary Intervention.  23:B1-B4. 2011
  • Transradial PCI in women: Problem solved or clinical equipoise?.  23:98-99. 2011
  • Is the Door-To-Balloon Metric a Pitfall to Improved Patient Outcomes?.  22:9C-12C. 2010
  • From theory to practice: implementation of pre-hospital electrocardiogram transmission in ST-elevation myocardial infarction - a multicenter experience..  22:520-525. 2010
  • Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials..  21:589-595. 2009
  • The association between the transradial approach for percutaneous coronary interventions and bleeding.  21:21-24. 2009
  • Response variability and the role of platelet function testing..  21:172-178. 2009
  • Using procedural approaches to reduce complications related to percutaneous coronary interventions.  21:2-. 2009
  • Clinical and angiographic outcomes in diabetic patients following single or multivessel stenting in the COSTAR II randomized trial..  20:335-341. 2008
  • Long-term survival using intra-aortic balloon pump and percutaneous right ventricular assist device for biventricular mechanical support of cardiogenic shock..  20:E205-E207. 2008
  • In-stent pseudo-restenosis due to an organized thrombus six months after implantation of a sirolimus-eluting stent.  19:145-148. 2007
  • Pharmacoinvasive management of acute coronary syndrome: Incorporating the 2007 ACC/AHA Guidelines: The CATH (Cardiac Catheterization and Antithrombotic Therapy in the Hospital) Clinical Consensus Panel Report - III.  19:525-540. 2007
  • Simultaneous restenosis of Taxus and Cypher drug-eluting stents..  18:557-560. 2006
  • Temporal trends in target vessel revascularization in clinical practice: long-term outcomes following coronary stenting from the Duke Database for Cardiovascular Disease..  18:398-402. 2006
  • Initial experience with a novel coronary rinsing and thrombectomy system: "Rinspiration"..  18:188-192. 2006
  • Late "adult form" scimitar syndrome presenting with "infant form" complications..  18:E82-E85. 2006
  • Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial..  17:360-364. 2005
  • Which is the true channel?.  16:716-718. 2004
  • Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience..  16:475-481. 2004
  • The bifurcation stent..  16:436-438. 2004
  • Clopidogrel dosing in overweight patients: does one size fit all?.  16:175-176. 2004
  • Percutaneous coronary revascularization in diabetic patients with multivessel coronary artery disease: importance and feasibility..  16:107-108. 2004
  • Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study..  15:699-702. 2003
  • Provisional stenting versus routine stenting: is it worth the price?.  15:634-635. 2003
  • The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results..  15:611-616. 2003
  • Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors with percutaneous coronary intervention in acute coronary syndromes..  15:460-465. 2003
  • Bivalirudin, thrombin and platelets: clinical implications and future directions..  Suppl:2-15. 2003
  • Radiocontrast nephropathy: a time for affirmative action..  15:23-25. 2003
  • Inflammation, platelets, and glycoprotein IIb/IIIa inhibitors..  14 Suppl E:18E-26E. 2002
  • The complementary use of glycoprotein IIb/IIIa inhibitors and drug-eluting stents in contemporary percutaneous coronary intervention..  14 Suppl E:36E-47E. 2002
  • Acute myocardial infarction in a young male while playing paintball..  14:713-715. 2002
  • Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study..  14:584-589. 2002
  • Integrating GP IIb/IIIa inhibition into treatment strategies for acute ST-elevation myocardial infarction..  14:565-574. 2002
  • Removal of thrombus by catheter aspiration prior to stenting..  14:474. 2002
  • An anomalous left coronary artery originating from the pulmonary artery in a 72-year-old woman: diagnosis by color flow myocardial blush and coronary arteriography..  14:96-99. 2002
  • The bent stent..  14:54-56. 2002
  • Congenital coarctation and Takayasu's arteritis: aortic stenting employing intravascular ultrasound..  13:705-707. 2001
  • Saphenous vein graft disease: a left main equivalent..  13:665-668. 2001
  • Acute myocardial infarction in a young female..  13:597-599. 2001
  • Extensive thrombus prior to elective percutaneous coronary intervention..  13:538-542. 2001
  • No jacket required..  13:516-518. 2001
  • Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention..  12 Suppl F:14F-149. 2000
  • Effects of 308 nanometer excimer laser energy on 316 L stainless-steel stents: implications for laser atherectomy of in-stent restenosis..  12:555-559. 2000
  • "Rescue" platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: bailing out of a sunken ship..  12:502-504. 2000
  • The association between institutional primary angioplasty procedure volume and outcome in elderly Americans..  12:303-308. 2000
  • Intervening on small infarct-related arteries: what does the future hold?.  12:20-22. 2000
  • Intracoronary thrombus: an ongoing challenge..  11:488-490. 1999
  • Platelet glycoprotein IIb/IIIa integrin inhibition in acute myocardial infarction..  11:494-499. 1999
  • Coronary interventions "to go": Is faster better?.  11:401-402. 1999
  • Post-pericardiotomy syndrome after percutaneous balloon pericardiotomy..  11:144-146. 1999
  • Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial..  8 Suppl B:21B-29B. 1996
  • The use of the Tracker catheter as a guidewire support device in angioplasty of angulated and tortuous circumflex coronary arteries..  7:66-71. 1995
  • Perfusion balloon angioplasty in patients with complex coronary lesion morphology..  7 Suppl B:4B-9B. 1995
  • Use of the perfusion balloon as a primary dilation device..  7 Suppl B:17B-24B. 1995
  • The impact of autoperfusion on quantitative electrocardiographic parameters of ischemia severity, extent, and "burden" during salvage of elective coronary angioplasty..  6:234-240. 1994
  • Dosing and administration of ReoPro (c7E3 Fab)..  6 Suppl A:29A-33A. 1994
  • UNTITLED.  6:A43-A56. 1994
  • Coronary transluminal extraction-endarterectomy..  3:13-18. 1991